Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 250 shares at $112.51 ($28K) on 2019-05-14, disclosed to the SEC on 2019-05-16.
Scheduled purchase ($28k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |